Table 1 Clinicopathologic features of this cohort.
Total | 371 | |
|---|---|---|
Gender (n/%) | Male | 187 (50.40%) |
Female | 184 (49.60%) | |
Age | Median (range) | 62 (27–84) |
Smoking status (n/%) | Smoking | 70 (18.87%) |
Nonsmoking | 110 (29.65%) | |
Unknown | 191 (51.48%) | |
TMB | Median (range) | 3 (0–55.7) |
Tumor sites (n/%) | Primary lesion | 297 (80.05%) |
Metastases lesion | 56 (15.09%) | |
Pleural | 26 (7.0%) | |
Lymphatic | 9 (2.43%) | |
Bone | 9 (2.43%) | |
Liver | 3 (0.81%) | |
brain | 2 (0.54%) | |
peritoneal | 2 (0.54%) | |
Adrenal gland | 1 (0.27%) | |
Unclear | 4 (1.08%) | |
Unknown | 18 (4.85%) | |
Tumor stage (n/%) | I | 42 (11.32%) |
II | 30 (8.09%) | |
III | 46 (12.40%) | |
IV | 121 (32.61%) | |
Unknown | 132 (35.58%) | |
Tumor subtype (n/%) | Non-small cell lung cancer | 335 (90.30%) |
Lung adenocarcinoma | 286 | |
Lung squamous cell carcinoma | 30 | |
Lung adenosquamous carcinoma | 8 | |
Unknown | 11 | |
Small cell lung cancer | 11 (2.97%) | |
Unknown | 25 (6.74%) | |
